introduction 1 this proceeding relates to an invention (the invention) the subject of australian patent no 729662 (the patent) and united states patent no 6,531,434 (the us patent).
a "continuation-in-part" (cip) application was also made in the united states in respect of the invention, and the subsequent patent granted was united states patent no 7,163,914 (the cip us patent).
each of the patent, the us patent and the cip us patent are held by the third respondent (novapharm).